Doctrina Raises €1,020,000 of New Capital

Doctrina, a start-up company transforming the traditional transfer of knowledge between pharmaceutical companies and pharmacies, has raised a total of €1,020,000 in series A funding. The investment will enable Doctrina to execute its growth plans and scale its solution to new markets.

"We are excited to receive the new capital from our investors," says Tomaž Erjavec, founder and managing partner of Doctrina. "Our goal is to make Doctrina an indispensable part of pharmacists' workdays with the mission to optimize the transfer of knowledge and patient safety."

Doctrina helps pharmacists to access knowledge about new pharmaceutical products and other professional novelties on one independent platform. Due to the amount of products each pharmacy offers, it's impossible for the employees of the pharmacies to keep track of all changes and innovations. Based on the fact that 87% of healthcare professionals conclude contact with a pharmaceutical sales rep in less than two minutes and that sales reps spend 50% of their working time in their cars, Doctrina has developed a signature technology that enables pharmaceutical companies to achieve greater reach, faster knowledge delivery with real-time feedback, and more efficient two-way communication. The method used to further train the pharmacists has been developed with the latest e-learning trends and is available in a video micro-learning format. This helps pharmacists and pharmaceutical technicians to access knowledge about products and all content in one place, anytime and on any device.

A substantial portion of investment will be used to execute the company's growth plans, which are focused on Poland and the UK, as well as some other smaller markets, but will also focus on further product development, and the expansion of the international team.

"Our platform is already used by 55,000 pharmacists from Poland, Russia, Slovenia, Romania and Croatia. The plan is to now bring our technology to other countries in Europe and enable pharmaceutical companies and pharmacists to increase the flow of effective knowledge transfer. We are also focusing on finding digital health enthusiasts to join our international team working on multiple markets." commented Jure Pučko, CEO and founder of Doctrina. "Our vision is to make Doctrina an indispensable daily source of product news and other professional information."

For further information, please visit:
https://en.doctrina.biz

About Doctrina
Doctrina is an online platform that allows pharmaceutical companies to further train pharmacy employees through webinars. It assists sales representative visits with greater and faster reach, lower costs, and accurate analytics. The platform is used daily by over 55,000 pharmacists from Slovenia, Romania, Poland, Russia and Croatia.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...